HMGB1 and central nervous system cancer: Similarly, given that NETs can promote the proliferation and invasion of glioma though the binding of HMGB1 and RAGE [110], it is also possible that the administration of anti-HMGB1 antibodies to glioma patients can inhibit the deterioration and progression of tumors induced by NETs.